(Q40987433)

25 September 2017

title

Direct action of a protein-bound polysaccharide, PSK, on transforming growth factor-beta (English)

1 reference

25 September 2017

1 reference

K Matsunaga

1

1 reference

25 September 2017

A Hosokawa

2

1 reference

25 September 2017

M Oohara

3

1 reference

25 September 2017

N Sugita

4

1 reference

25 September 2017

M Harada

5

1 reference

25 September 2017

K Nomoto

6

1 reference

25 September 2017

publication date

1 November 1998

1 reference

25 September 2017

1 reference

25 September 2017

volume

40

1 reference

25 September 2017

issue

3

1 reference

25 September 2017

page(s)

219-230

1 reference

Transforming growth factor beta 1: secondary structure as determined by heteronuclear magnetic resonance spectroscopy

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2898%2900045-9

7 January 2021

Altered metabolic and adhesive properties and increased tumorigenesis associated with increased expression of transforming growth factor beta 1

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2898%2900045-9

7 January 2021

Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2898%2900045-9

7 January 2021

Crystal structure of transforming growth factor-beta 2: an unusual fold for the superfamily

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2898%2900045-9

7 January 2021

Oral administration of PSK can improve the impaired anti-tumor CD4+ T-cell response in gut-associated lymphoid tissue (GALT) of specific-pathogen-free mice

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2898%2900045-9

7 January 2021

The therapeutic effects of an immunopotentiator, PS-K, on 3-methylcholanthrene-induced autochthonous tumors in C57BL/6 mice in combination with the surgical removal of primary sites

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2898%2900045-9

7 January 2021

The effect of transforming growth factor-beta 2-specific phosphorothioate-anti-sense oligodeoxynucleotides in reversing cellular immunosuppression in malignant glioma

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2898%2900045-9

7 January 2021

Interactions between cytokines and α2-macroglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2898%2900045-9

7 January 2021

Transforming growth factor-beta (TGF-beta)-mediated immunosuppression in the tumor-bearing state: enhanced production of TGF-beta and a progressive increase in TGF-beta susceptibility of anti-tumor CD4+ T cell function.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2898%2900045-9

7 January 2021

A simplified representation of protein conformations for rapid simulation of protein folding

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2898%2900045-9

7 January 2021

Proteolytic activation of latent transforming growth factor-beta from fibroblast-conditioned medium

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2898%2900045-9

7 January 2021

Randomized, controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer. The Cooperative Study Group of Surgical Adjuvant Immunochemotherapy for Cancer of Colon and Rectum (Kanagawa).

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2898%2900045-9

7 January 2021

Transforming growth factor-beta complexes with thrombospondin

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2898%2900045-9

7 January 2021

Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer. Study Group of Immunochemotherapy with PSK for Gastric Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2898%2900045-9

7 January 2021

Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2898%2900045-9

7 January 2021

An unusual feature revealed by the crystal structure at 2.2 A resolution of human transforming growth factor-beta 2

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2898%2900045-9

7 January 2021

Transforming growth factor-beta: recent progress and new challenges

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2898%2900045-9

7 January 2021

Hydrazinolysis of asparagine-linked sugar chains to produce free oligosaccharides

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2898%2900045-9

7 January 2021

Blocking of lymphocyte surface binding sites for the soluble suppressor factor by protein-bound polysaccharide, PSK.

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2898%2900045-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0162-3109%2898%2900045-9

1 reference

7 January 2021

Excessive production of transforming growth-factor beta 1 can play an important role in the development of tumorigenesis by its action for angiogenesis: validity of neutralizing antibodies to block tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2898%2900045-9

7 January 2021

Suramin interference with transforming growth factor-beta inhibition of human renal cell carcinoma in culture

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2898%2900045-9

7 January 2021

Distribution and modulation of the cellular receptor for transforming growth factor-beta

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2898%2900045-9

7 January 2021

Transforming growth factor-beta-mediated down-regulation of antitumor cytotoxicity of spleen cells from MOPC-315 tumor-bearing mice engaged in tumor eradication following low-dose melphalan therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2898%2900045-9

7 January 2021

Negative regulation of transforming growth factor-beta by the proteoglycan decorin

1 reference

https://api.crossref.org/works/10.1016%2FS0162-3109%2898%2900045-9

7 January 2021

10.1016/S0162-3109(98)00045-9

Identifiers

DOI

1 reference

25 September 2017

1 reference